INS and obesity disorder: In obesity and IR, adipokine profiles are altered, with molecules such as CTRP3 (which enhances insulin sensitivity via AMPK activation) and WISP1 (which impairs insulin signaling through IRS-1 phosphorylation) playing opposing roles [102].